Introduction The clinical management of Obstructive Hypertrophic Cardiomyopathy remains challenging, and the phase III EXPLORER-HCM trial has demonstrated that the novel cardiac myosin inhibitor ...

A more detailed understanding of customer-level costs is increasingly influencing strategic decisions related to ...

For the initial evaluation of low-risk patients with stable chest pain, anatomic testing—coronary CT angiography (CTA) with or without noninvasive fractional flow reserve (FFR)—is cost-effective ...

This is an overview of what cost analysis is all about, the types of cost analyses we implement at the IRC and what kinds of questions they can answer. Watch the full Cost analysis in Excel playlist.